Online Event
Biopharma companies face unique challenges in scaling AI-and those challenges vary greatly depending on whether you’re at a small or large biopharma. While large biopharma is pushing ahead with nearly 3x the rate of AI adoption of smaller companies (73% vs. 26%), gaps in AI readiness are evident across both segments, according to the upcoming State of Tech in Biopharma report. Just 14% of large biopharma and 3% of small biopharma report being fully prepared for AI across the critical dimensions of
